Minimal Fluoroscopic Catheter Ablation for Adult Patients with Paroxysmal Supraventricular Tachycardia without the Assistance of Intracardiac Echocardiography

Acta Cardiol Sin. 2023 Jul;39(4):546-560. doi: 10.6515/ACS.202307_39(4).20230111A.

Abstract

Background: Radiation exposure during fluoroscopic procedures increases the risk of cancer for both patients and operators.

Objectives: The aim of this study was to investigate the safety and efficacy of adopting a three-dimensional electroanatomical mapping (3D EAM) system during ablation for paroxysmal supraventricular tachycardia (PSVT), without the assistance of intracardiac echocardiography (ICE), for both right- and left-chamber cardiac procedures.

Methods: We retrospectively enrolled all patients with PSVT from September 2018 to December 2020. The patients were grouped according to the use of the 3D EAM system (3D-guided group, n = 102 vs. conventional group, n = 226).

Results: The acute success rates were high in both groups (100% vs. 99.1%). The fluoroscopy time was significantly lower in the 3D-guided group than in the conventional group (2.4 ± 4.4 vs. 19.0 ± 10.8 min); the procedure time was significantly increased in the 3D-guided group (104.5 ± 29.9 vs. 94.0 ± 31.9 min), and this was associated with the post-electrophysiology test diagnosis after adjustment for multiple variables [standardized B coefficient (β) 0.188]. There was no learning curve for each electrophysiologist in terms of fluoroscopy and procedure times.

Conclusions: The 3D EAM system, without the assistance of ICE, was safe and effective in guiding PSVT ablation in both left- and right-chamber ablation.

Keywords: Catheter ablation (CA); Nonfluroscope (NF); Paroxysmal supraventricular tachycardia (PSVT); Three-dimensional electroanatomical system (3D EAM).